Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-15

FDA Approved: ZORYVE — Original Application (Arcutis Biotherapeutics, Inc.)

View source ↗

Summary

FDA approved ZORYVE (roflumilast) topical cream as an original application for treating plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZORYVE (ROFLUMILAST)

Snippet

ORIG AP for ZORYVE (ROFLUMILAST)